⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Pomerantz LLP Shares Class Action Details With Investors in Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
accessnewswire.com
EYPT
REGN
Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. (REGN) Investors – Lead Plaintiff Deadline on September 14, 2026
accessnewswire.com
REGN
REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) – Recover Losses – Contact Levi & Korsinsky Before September 14, 2026
accessnewswire.com
REGN
Pomerantz LLP Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Pomerantz LLP Reminds Shareholders: Securities Lawsuit Has Been Filed Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
accessnewswire.com
EYPT
REGN
Contact Levi & Korsinsky by September 14, 2026 to Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
Pomerantz LLP Issues Alert Regarding Shareholder Class Action Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN